New Gene Therapy Rapidly Helps Patients With Rare Blood Disorder.
Two patients who were given Bluebird Bio’s experimental gene therapy for the rare blood disorder beta-thalassemia were able to stop receiving blood transfusions within 12 days of receiving the trea…
